1331. What Research do Clinicians Want? A survey of Infectious Diseases Physicians
Session: Poster Abstract Session: Clinical Trials
Saturday, October 5, 2013
Room: The Moscone Center: Poster Hall C
  • IDweekposter.pdf (417.5 kB)
  • Background: The Australasian Society for Infectious Diseases Clinical Research Network (ASID CRN) is a community of experienced clinicians and researchers across Australia and New Zealand, who aim to improve patient outcomes through quality advancements in Infectious Diseases (ID) research. In 2012, the ASID CRN devised a series of surveys targeted at identifying what these clinicians and researchers perceive as priorities that need addressing through clinician-initiated studies. Initial results showed an enthusiastic acknowledgment of over 100 top research priorities, with an end result converging into a well diversified “short list” of current research topics.

    Methods: A self-reported online survey identifying over 100 potentials for studies in the topics of randomized control trials (RCTs), epidemiology and observational/registry in ID, was designed and distributed through an Australasian ID e-mailing server. Questions answered by rating scales produced an end result of a top ranked “short list” that was selected by the ASID CRN to be distributed and evaluated by the Australian and New Zealand ID community. Survey questions pertaining to barriers of recruitment including site feasibility were also assessed.

    Results: 122 ID Physicians responded to the survey. The top ranked RCTs were in the field of antibiotic management of prosthetic joint infections (mean rank 3.97), native joint septic arthritis or osteomyelitis (mean rank 3.83), duration of therapy for Staphylococcus aureus bloodstream infection (BSI) (mean rank 3.82), antibiotic management of diabetic foot infection (mean rank 3.74) and antibiotic choice for BSI of ESBL producing organisms (mean rank 3.43). Lack of funding (mean rank 4.26), research staffing resources (mean rank 4.00) and time-constraints with existing clinical duties (mean rank 3.92) were highly ranked amongst feasibility barriers to sites performing future clinical research.

    Conclusion: Clinician-initiated research has many advantages over industry sponsored research. It seeks to answer areas of greatest priority for clinicians. The potential cost benefits of reducing duration of antibiotics or comparing outcomes with inexpensive generic antibiotics should be driving forces for increasing funding of this type of research activity.

    Tiffany M. Brown, BSN RN, MPH, Infection and Immunity Theme, The University of Queensland Centre for Clinical Research, Herston, Australia, David L. Paterson, MD PhD, University of Queensland Centre for Clinical Research (UQCCR), Brisbane, Australia and The Australasian Society for Infectious Diseases Clinical Research Network


    T. M. Brown, None

    D. L. Paterson, None

    See more of: Clinical Trials
    See more of: Poster Abstract Session

    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.